DexCare, Inc. — SEC Form D Filing

DexCare, Inc. filed an SEC Form D on September 14, 2026, reporting $12.93M raised in Healthcare Technology.

Form D filing details

Filing
SEC Form D
Filing date
September 14, 2026
Amount reported
$12.93M
Round stage
Series B+
Industry
Healthcare Technology
Website
https://dexcare.com/

What the company does

Securities: Equity. Exemption: Rule 506(b). Incorporated: DELAWARE

Problem

Health systems suffer from fragmented systems and data, leading to inconsistent access decisions across different patient entry points, patient dead ends, and empty appointment slots. Patients struggle to navigate care efficiently and book available appointments.

Solution

DexCare provides a unified navigation layer that routes patients to appropriate care by structuring fragmented data, centralizing routing rules, and executing consistent access decisions across all channels (web, mobile, call centers). This system optimizes scheduling, fills capacity, and reduces patient wait times.

Why now

The increasing demand for digital access in healthcare, coupled with system fragmentation and provider shortages, creates a critical need for solutions that optimize patient flow and resource utilization without adding staff.

Verdict

This cleared because investors saw a clear path to cost savings and operational efficiency for health systems grappling with digital patient access, not because DexCare was introducing net-new patient demand. They were implicitly betting that large health systems would prioritize backend optimization over direct patient acquisition tools, willing to invest in infrastructure that promised to reduce internal friction and better utilize existing capacity. The upside was inherently limited by the pace of enterprise healthcare IT adoption and the challenge of integrating into deeply entrenched, heterogeneous legacy systems.

Source: SEC EDGAR Form D filing